ARK Investment Management LLC and Catherine D. Wood filed Amendment No. 2 to Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 1,913,123 shares of GeneDx Holdings Corp. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: ARK Investment Management LLC and Catherine D. Wood each reported beneficial ownership of 1,913,123 shares of GeneDx Holdings Corp. common stock.
  • Percent of class: The 1,913,123 shares represent 6.42% of the class, according to the filing.
  • ARK voting and dispositive power: ARK reported sole voting power over 1,815,108 shares, shared voting power over 26,835 shares, and sole dispositive power over 1,913,123 shares.
  • Catherine D. Wood's power: Wood reported shared voting power over 1,841,943 shares and shared dispositive power over 1,913,123 shares, with zero sole voting or dispositive power.
  • Triggering event date: The date of the event requiring this filing was September 30, 2026.
  • Filer type: ARK is classified as an investment adviser (IA); Wood is classified as a holding company and individual (HC, IN).

ARK Investment Management and Catherine Wood Disclose GeneDx Holdings Position

ARK Investment Management LLC, a Delaware-organized investment adviser, and Catherine D. Wood, its Chief Executive Officer and Chief Investment Officer, jointly filed Amendment No. 2 to Schedule 13G on November 13, 2026, covering common stock of GeneDx Holdings Corp. (CUSIP 81663L200). The filing was triggered by an event dated September 30, 2026, and the two reporting persons share the same principal business address at 200 Central Avenue, St. Petersburg, FL 33701.

According to the filing, the aggregate amount beneficially owned by each reporting person is 1,913,123 shares, equaling 6.42% of the class. ARK holds sole voting power over 1,815,108 shares and shared voting power over 26,835 shares. ARK also retains sole dispositive power over all 1,913,123 shares, with no shared dispositive power reported. Wood, in contrast, reports no sole voting or dispositive authority; she reports shared voting power over 1,841,943 shares and shared dispositive power over the full 1,913,123 shares.

The filing certifies, as required under Schedule 13G, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The statement was signed by Kathleen Fontano, Chief Compliance Officer of ARK, and by Catherine D. Wood, on November 13, 2026.

What Was Disclosed

ARK Investment Management LLC and Catherine D. Wood disclosed a combined beneficial ownership of 1,913,123 shares, or 6.42%, of GeneDx Holdings Corp. common stock as of September 30, 2026, via Amendment No. 2 to Schedule 13G filed November 13, 2026.